Harvard Bioscience, Inc. (HBIO) Improves Q3 EPS to 8c Amid Lower Sales
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.33 +3.61%
Revenue Growth %: +6.1%
Financial Fact:
Gross Profit: 11.69M
Today's EPS Names:
RCBC, GASS, YSG, More
Revenue Growth %: +6.1%
Financial Fact:
Gross Profit: 11.69M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q3 EPS of $0.08, versus $0.07 reported last year. Revenue for the quarter came in at $26.1 million, versus $26.4 million reported last year.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- William Blair upgrades GitLab to Market Perform after strong second quarter
- Lakeland wins firefighting gear contract with Airports of Thailand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
